Fatigue and Lifestyle Physical Activity in SLE
SLE 患者的疲劳和生活方式体力活动
基本信息
- 批准号:8318574
- 负责人:
- 金额:$ 17.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-01 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAnxietyAutoimmune DiseasesBehaviorChildChronicChronic DiseaseChronically IllClinicalCognitiveCommunitiesCross-Sectional StudiesDataDevelopmentDiseaseExcess MortalityExerciseFatigueFrequenciesFundingFutureGoalsGuidelinesHealthHealth Care CostsHealth SurveysHouseholdIndividualInflammatoryInformation SystemsInterventionLife StyleLightLupusMalignant NeoplasmsMeasurementMeasuresMental DepressionMonographMorbidity - disease rateMovementMultiple SclerosisMuscleNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNaturePain interferencePatient Outcomes AssessmentsPatient Self-ReportPatientsPersonsPhysical activityPhysiciansPlayPopulationQuality of lifeResearchResearch DesignResearch PriorityRheumatoid ArthritisRiskSeveritiesSleepSurvey MethodologySymptomsSystemic Lupus ErythematosusTestingTransportationUnited States National Institutes of HealthWalkingWorkcombat fatiguecomputerizeddisabilityeconomic implicationeffective interventionimprovednew technologynovelprimary outcomeprogramssocialstandardize measuretool
项目摘要
DESCRIPTION (provided by applicant): Systemic lupus erythematosus (SLE) affects up to 1.5 million persons in the US. Although excess mortality has decreased in SLE patients since the 1970's, substantial morbidity persists. Fatigue is the most disabling and enduring complaint in patients affected with this chronic incurable inflammatory autoimmune disease. The ramifications of fatigue are significant and include decreased quality of life, an increased risk of work disability, and an associated increase in health care costs. The overarching goal of this R21 application is to explore ways to improve the measurement of two constructs, physical activity and fatigue, as a necessary first step in a broader effort to use a behavior management intervention to lower fatigue scores by increasing lifestyle physical activity in persons with SLE. We propose a novel application of a relatively new technology to objectively measure physical activity (triaxial accelerometry, which provides a validated measurement of daily physical activity in the community dwelling setting). In addition, we propose to measure covariates of fatigue using computerized adaptive tests (CATs) patient-reported outcomes (PROs) that have been developed using state-of-the-art cognitive, qualitative, quantitative and health survey methodologies as part of the NIH-funded Patient-Reported Outcomes Measurement Information System (PROMIS). PROMIS tools were developed to standardize measurement of self-reported health domains affected by many chronic illnesses and these tools offer the advantages of minimizing patient burden and maximizing precision. Using a cross-sectional study design, the following specific aims will be tested in this R21 application: Aim 1. Evaluate the frequency, intensity, and duration of physical activity as measured by accelerometry to obtain patient-specific average daily activity counts, average daily moderate-to- vigorous minutes of activity (MVPA) (defined as e 2020 activity counts/min), average daily minutes of light physical activity (< 2020 activity counts/min), and average daily minutes of any activity (i.e., minutes of non-zero activity counts) in patients with SLE. Aim 2. Characterize the cross-sectional relationships between objectively measured physical activity and fatigue (primary outcome, Fatigue Severity Score, (FSS) in patients with SLE. We will do this with and without adjustment for the major factors that influence fatigue including sleep and wake disturbance, depression, anxiety, and pain interference using PROMIS tools, and SLE disease activity and severity. The adverse clinical, social, and economic implications of fatigue support the critical need for an improved understanding of factors contributing to fatigue in SLE, a research priority identified in the NIH/NIAMS monograph entitled, "The Future Directions of Lupus Research".
描述(由申请人提供):系统性红斑狼疮 (SLE) 在美国影响多达 150 万人。尽管自 20 世纪 70 年代以来 SLE 患者的超额死亡率有所下降,但发病率仍然很高。对于患有这种慢性不可治愈的炎症性自身免疫性疾病的患者来说,疲劳是最严重和最持久的症状。疲劳的后果是显着的,包括生活质量下降、工作残疾风险增加以及相关的医疗费用增加。该 R21 应用程序的总体目标是探索改进对身体活动和疲劳这两个概念的测量的方法,这是使用行为管理干预措施通过增加人们的生活方式身体活动来降低疲劳分数的更广泛努力的必要的第一步患有系统性红斑狼疮。我们提出了一种相对较新的技术的新颖应用来客观地测量身体活动(三轴加速度测量法,它提供了社区住宅环境中日常身体活动的有效测量)。此外,我们建议使用计算机自适应测试 (CAT) 患者报告结果 (PRO) 来测量疲劳协变量,这些测试是使用最先进的认知、定性、定量和健康调查方法开发的,作为 NIH 的一部分-资助患者报告结果测量信息系统(PROMIS)。 PROMIS 工具的开发是为了标准化受许多慢性疾病影响的自我报告健康领域的测量,这些工具具有最小化患者负担和最大化精度的优点。 使用横断面研究设计,在此 R21 应用程序中将测试以下具体目标: 目标 1. 评估通过加速度计测量的身体活动的频率、强度和持续时间,以获得患者特定的平均每日活动计数、平均每日活动次数中度至剧烈活动分钟数 (MVPA)(定义为 2020 年活动次数/分钟)、轻度体力活动的平均每日分钟数(< 2020 年活动次数/分钟)以及任何活动的每日平均分钟数(即非零活动计数的分钟数)SLE 患者。 目标 2. 描述 SLE 患者客观测量的身体活动与疲劳之间的横截面关系(主要结果,疲劳严重程度评分 (FSS))。我们将在调整或不调整影响疲劳的主要因素(包括睡眠和疲劳)的情况下进行此研究。疲劳的不利临床、社会和经济影响表明迫切需要更好地了解导致 SLE 疲劳的因素(一项研究)。确定优先事项NIH/NIAMS 题为“狼疮研究的未来方向”的专着中。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Fatigue in systemic lupus erythematosus.
- DOI:10.2217/ijr.12.4
- 发表时间:2012-04-01
- 期刊:
- 影响因子:0
- 作者:Ahn GE;Ramsey-Goldman R
- 通讯作者:Ramsey-Goldman R
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rosalind Ramsey-Goldman其他文献
Rosalind Ramsey-Goldman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rosalind Ramsey-Goldman', 18)}}的其他基金
Differentiating clinical characteristics between two subtypes of antiphosphatidylethanolamine
区分抗磷脂酰乙醇胺两种亚型的临床特征
- 批准号:
10654055 - 财政年份:2022
- 资助金额:
$ 17.17万 - 项目类别:
Differentiating clinical characteristics between two subtypes of antiphosphatidylethanolamine
区分抗磷脂酰乙醇胺两种亚型的临床特征
- 批准号:
10510394 - 财政年份:2022
- 资助金额:
$ 17.17万 - 项目类别:
Cancer risk after renal transplant in autoimmune disease
自身免疫性疾病肾移植后的癌症风险
- 批准号:
8387402 - 财政年份:2012
- 资助金额:
$ 17.17万 - 项目类别:
Cancer risk after renal transplant in autoimmune disease
自身免疫性疾病肾移植后的癌症风险
- 批准号:
8507183 - 财政年份:2012
- 资助金额:
$ 17.17万 - 项目类别:
Fatigue and Lifestyle Physical Activity in SLE
SLE 患者的疲劳和生活方式体力活动
- 批准号:
8114607 - 财政年份:2011
- 资助金额:
$ 17.17万 - 项目类别:
Study of Lupus Vascular and Bone Longterm Endpoints
狼疮血管和骨骼长期终点研究
- 批准号:
7665020 - 财政年份:2008
- 资助金额:
$ 17.17万 - 项目类别:
Study of Lupus Vascular and Bone Longterm Endpoints
狼疮血管和骨骼长期终点研究
- 批准号:
7267276 - 财政年份:2007
- 资助金额:
$ 17.17万 - 项目类别:
PREDICTORS OF PREGNANCY OUTCOMES IN SLE AND APS
SLE 和 APS 妊娠结局的预测因素
- 批准号:
7604310 - 财政年份:2006
- 资助金额:
$ 17.17万 - 项目类别:
TRANSESOPHAGEAL ECHOCARDIOGRAPHY EVALUATION AND MRI OF THE AORTA IN LUPUS
狼疮主动脉的经食管超声心动图评估和 MRI
- 批准号:
7604326 - 财政年份:2006
- 资助金额:
$ 17.17万 - 项目类别:
EPIDEMIOLOGY OF OSTEOPOROSIS IN WOMEN WITH LUPUS - MAMDC PROJECT
狼疮女性骨质疏松症的流行病学 - MAMDC 项目
- 批准号:
7604235 - 财政年份:2006
- 资助金额:
$ 17.17万 - 项目类别:
相似国自然基金
腹侧海马铁代谢紊乱对衰老相关焦虑表型的影响及其调控机制
- 批准号:82371591
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
星形胶质细胞Netrin-1通过调控小胶质细胞TNFα释放影响小鼠焦虑易感性的作用及机制研究
- 批准号:32371039
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
考试焦虑影响测试策略使用和学习成绩的认知神经机制与干预研究
- 批准号:32371116
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
无意识恐惧影响青少年焦虑的认知神经机制及其干预研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
肠道副萨特氏菌属影响色氨酸代谢在前庭功能异常-焦虑共病症中的作用机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Mental Health and Occupational Functioning in Nurses: An investigation of anxiety sensitivity and factors affecting future use of an mHealth intervention
护士的心理健康和职业功能:焦虑敏感性和影响未来使用移动健康干预措施的因素的调查
- 批准号:
10826673 - 财政年份:2024
- 资助金额:
$ 17.17万 - 项目类别:
Developing and Evaluating a Positive Valence Treatment for Alcohol Use Disorder with Anxiety or Depression
开发和评估治疗伴有焦虑或抑郁的酒精使用障碍的正价疗法
- 批准号:
10596013 - 财政年份:2023
- 资助金额:
$ 17.17万 - 项目类别:
Integration of stepped care for Perinatal Mood and Anxiety Disorders among Women Living with HIV in Kenya
肯尼亚艾滋病毒感染妇女围产期情绪和焦虑障碍的分级护理一体化
- 批准号:
10677075 - 财政年份:2023
- 资助金额:
$ 17.17万 - 项目类别:
Involvement of dopamine signaling in chronic pain-induced negative affective state and nicotine use comorbidity
多巴胺信号传导参与慢性疼痛引起的负面情感状态和尼古丁使用合并症
- 批准号:
10662951 - 财政年份:2023
- 资助金额:
$ 17.17万 - 项目类别:
Characterizing the genetic etiology of delayed puberty with integrative genomic techniques
利用综合基因组技术表征青春期延迟的遗传病因
- 批准号:
10663605 - 财政年份:2023
- 资助金额:
$ 17.17万 - 项目类别: